Follow
Filip Mundt
Filip Mundt
Senior scientist in Matthias Mann's group at the NNF Center for Protein Research
Verified email at cpr.ku.dk
Title
Cited by
Cited by
Year
Proteogenomics connects somatic mutations to signalling in breast cancer
P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ...
Nature 534 (7605), 55-62, 2016
15262016
Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry
P Mertins, LC Tang, K Krug, DJ Clark, MA Gritsenko, L Chen, KR Clauser, ...
Nature protocols 13 (7), 1632-1661, 2018
3772018
A curated resource for phosphosite-specific signature analysis*[S]
K Krug, P Mertins, B Zhang, P Hornbeck, R Raju, R Ahmad, M Szucs, ...
Molecular & cellular proteomics 18 (3), 576-593, 2019
2062019
Proteomics, post-translational modifications, and integrative analyses reveal molecular heterogeneity within medulloblastoma subgroups
TC Archer, T Ehrenberger, F Mundt, MP Gold, K Krug, CK Mah, ...
Cancer cell 34 (3), 396-410. e8, 2018
1712018
Fast type I interferon response protects astrocytes from flavivirus infection and virus-induced cytopathic effects
R Lindqvist, F Mundt, JD Gilthorpe, S Wölfel, NO Gekara, A Kröger, ...
Journal of neuroinflammation 13, 1-15, 2016
1452016
A knowledge graph to interpret clinical proteomics data
A Santos, AR Colaço, AB Nielsen, L Niu, M Strauss, PE Geyer, F Coscia, ...
Nature biotechnology 40 (5), 692-702, 2022
1322022
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
HJ Johansson, BC Sanchez, F Mundt, J Forshed, A Kovacs, E Panizza, ...
Nature communications 4 (1), 2175, 2013
732013
Integrated multi-omic analysis of host-microbiota interactions in acute oak decline
M Broberg, J Doonan, F Mundt, S Denman, JE McDonald
Microbiome 6, 1-15, 2018
632018
Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration
F Zong, E Fthenou, F Mundt, T Szatmári, I Kovalszky, L Szilák, D Brodin, ...
PLoS One 6 (6), e14816, 2011
612011
Mass spectrometry–based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibition in triple-negative breast cancers
F Mundt, S Rajput, S Li, KV Ruggles, AD Mooradian, P Mertins, ...
Cancer research 78 (10), 2732-2746, 2018
572018
Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma
F Mundt, HJ Johansson, J Forshed, S Arslan, M Metintas, K Dobra, ...
Molecular & Cellular Proteomics 13 (3), 701-715, 2014
532014
Hyaluronan and N-ERC/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma
F Mundt, G Nilsonne, S Arslan, K Csürös, G Hillerdal, H Yildirim, ...
PLoS One 8 (8), e72030, 2013
492013
Novel genes and pathways modulated by syndecan-1: implications for the proliferation and cell-cycle regulation of malignant mesothelioma cells
T Szatmári, F Mundt, G Heidari-Hamedani, F Zong, E Ferolla, ...
PloS one 7 (10), e48091, 2012
482012
Clinical knowledge graph integrates proteomics data into clinical decision-making
A Santos, AR Colaço, AB Nielsen, L Niu, PE Geyer, F Coscia, ...
bioRxiv, 2020.05. 09.084897, 2020
462020
Diagnostic and prognostic value of soluble syndecan-1 in pleural malignancies
F Mundt, G Heidari-Hamedani, G Nilsonne, M Metintas, A Hjerpe, K Dobra
BioMed Research International 2014, 2014
382014
Molecular targets and signaling pathways regulated by nuclear translocation of syndecan-1
T Szatmári, F Mundt, A Kumar-Singh, L Möbus, R Ötvös, A Hjerpe, ...
BMC Cell Biology 18, 1-20, 2017
292017
Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy
A Szulkin, G Nilsonne, F Mundt, AM Wasik, P Souri, A Hjerpe, K Dobra
PLoS One 8 (6), e65903, 2013
262013
Phenotype-dependent apoptosis signalling in mesothelioma cells after selenite exposure
G Nilsonne, E Olm, A Szulkin, F Mundt, A Stein, B Kocic, AK Rundlöf, ...
Journal of Experimental & Clinical Cancer Research 28, 1-12, 2009
262009
Organ-specific metabolic pathways distinguish prediabetes, type 2 diabetes, and normal tissues
K Diamanti, M Cavalli, MJ Pereira, G Pan, C Castillejo-Lopez, C Kumar, ...
Cell Reports Medicine 3 (10), 2022
142022
A highly multiplexed quantitative phosphosite assay for biology and preclinical studies
H Keshishian, ER McDonald III, F Mundt, R Melanson, K Krug, DA Porter, ...
Molecular Systems Biology 17 (9), e10156, 2021
112021
The system can't perform the operation now. Try again later.
Articles 1–20